Pressroom

See all trending topics »Trending Topics

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator »

USPSTF Releases Final Recommendations on Use of Breast Cancer Prevention Drugs

The US Preventive Services Task Force has recommended that breast cancer primary prevention drugs be offered to higher-risk women at low risk of side effects. Memorial Sloan-Kettering’s Chief of Breast Cancer Medicine, Clifford Hudis, is available to discuss

Wednesday, September 25, 2013
Major Developments in Radiation Therapy: ASTRO Annual Meeting

The largest radiation oncology event in the world, the ASTRO annual meeting, will take place in Atlanta, September 22-25. Memorial Sloan-Kettering radiation oncologists are available to comment on breaking news out of the meeting.

Friday, September 20, 2013
Is Breast Cancer Being Overtreated?

Women with breast cancer and relatively favorable prognoses often face treatment choices that balance small gains in outcome with possible negative effects. Medical oncologist Larry Norton and breast surgeon Monica Morrow are available to weigh in on this topic.

Friday, August 2, 2013

See all press releases »Press Releases

Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College, and Partnership Formed with Takeda

Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. and have partnered with Takeda Pharmaceutical Company, Ltd.

Tuesday, October 1, 2013
Pictured: Levi A. Garraway; Duojia (DJ) Pan; and Simon J. Boulton
Three Young Investigators Named Winners of Paul Marks Prize for Cancer Research

Memorial Sloan-Kettering Cancer Center has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research.

Monday, September 23, 2013
Memorial Sloan-Kettering Leads Initiative to Reduce Health Disparities in U.S. South Asian Population

Memorial Sloan-Kettering Cancer Center is leading an innovative initiative to reduce cancer and cardiovascular health disparities in South Asian immigrant communities in the United States.

Thursday, September 19, 2013

See all story starters »Story Starters

Need story ideas? Use our evergreen story suggestions to generate new content or complement something you're already working on.

Complementary Therapies Help Cancer Patients Improve Quality of Life
Screening Smarter for Prostate Cancer
A Unique Writing Program for Cancer Patients

See all blog posts »On Our Blog

Perspective
Cancer Care in the United States: Newly Released IOM Report Details a “System in Crisis”

Memorial Sloan-Kettering experts comment on the latest findings by the Institute of Medicine about the quality, coordination, and cost of cancer care.

Thursday, October 3, 2013
Pictured: Pseudomonas aeruginosa
Snapshot
The Social Behavior of Bacteria Offers New Ideas for Antimicrobial Drug Design

Memorial Sloan-Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

Tuesday, October 1, 2013
Pictured: David Jones & Charles Rudin
Announcement
New Leaders in Memorial Sloan-Kettering Thoracic Surgery and Oncology

Thoracic surgeon David Jones and medical oncologist Charles Rudin, internationally recognized leaders in their fields, to head the Thoracic Surgical Service and the Thoracic Oncology Service, respectively.

Monday, September 30, 2013

See all media coverage »Media Coverage

What Breast Cancer Doctors Tell Their Friends

Surgical oncologist Deborah Capko offered advice for women newly diagnosed with breast cancer.

Sunday, September 1, 2013
A Disease by Any Other Name: The Cancer Conundrum

Head and neck cancer surgeon Bhuvanesh Singh commented on a paper that found that the number of cases of thyroid cancer in the United States tripled from 1973 to 2009, largely due to more aggressive screening techniques and improved imaging.

Tuesday, August 27, 2013
Kidney Cancer Drugs Equal in Prolonging Survival: Study

Medical oncologist Robert Motzer discussed a study he led that showed that the drug pazopanib works as well as sunitinib for treating advanced kidney cancer.

Thursday, August 22, 2013

Contact Media Staff

Jeanne D'Agostino
Media Relations Manager
646-227-3137
Courtney Nowak
Senior Media Relations Associate
646-227-3633
Caitlin Hool
Media Relations Associate
646-227-3956
Andrea Molinatti
Media Specialist
646-227-3139

Any of our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.

After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to Our
E-Newsletter

Our e-mail newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign Up

Read recent issues »